TOFACITINIB CITRATE | A218900 | SAPTALIS PHARMACEUTICALS LLC
1 strength0 unique patents0 unique exclusivities
Reference Listed Drug: XELJANZ(TE code: AA) Products (1)
No patent or exclusivity listings for this strength.
ADDED7/1/2026
Saptalis Pharms received FDA approval for tofacitinib citrate (NDA 218900, strength 001), establishing a new drug product record in the Orange Book.